| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |